Tuesday, February 17, 2015 11:37:24 AM
I dont need cheerleaders. You have some issues
1. Company has proven their capabilities
2. Do we all understand that biosimilars are in flux due to regulatory, company specific priorities/reorganization...apparently you do not comprehend this part and you keep unloading on MNTA
3. MNTA got 90MM to support their 6-7 molecules with Baxter and to support their corporate expenses and now MNTA owns the rights to all except HUmira
What part of partnering and covering development expenses you dont get? Would it be better to raise funds otherwise?
Jbog...go save the biotech world and investors
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
